{
    "title": "Congenital Heart Futures Reauthorization Act of 2017",
    "content": "SECTION 1. SHORT TITLE.\n    This Act may be cited as the ``Congenital Heart Futures \nReauthorization Act of 2017''.\nSEC. 2. NATIONAL CONGENITAL HEART DISEASE RESEARCH, SURVEILLANCE, AND \nAWARENESS.\n    Section 399V-2 of the Public Health Service Act (42 U.S.C. 280g-13) \nis amended to read as follows:\n``SEC. 399V-2. NATIONAL CONGENITAL HEART DISEASE RESEARCH, \nSURVEILLANCE, AND AWARENESS.\n    ``(a) In General.--The Secretary shall, as appropriate--\n        ``(1) enhance and expand research and data collection efforts \n    related to congenital heart disease, including to study and track \n    the epidemiology of congenital heart disease to understand health \n    outcomes for individuals with congenital heart disease across all \n    ages;\n        ``(2) conduct activities to improve public awareness of, and \n    education related to, congenital heart disease, including care of \n    individuals with such disease; and\n        ``(3) award grants to entities to undertake the activities \n    described in this section.\n    ``(b) Activities.--\n        ``(1) In general.--The Secretary shall carry out activities, \n    including, as appropriate, through a national cohort study and a \n    nationally-representative, population-based surveillance system, to \n    improve the understanding of the epidemiology of congenital heart \n    disease in all age groups, with particular attention to--\n            ``(A) the incidence and prevalence of congenital heart \n        disease in the United States;\n            ``(B) causation and risk factors associated with, and \n        natural history of, congenital heart disease;\n            ``(C) health care utilization by individuals with \n        congenital heart disease;\n            ``(D) demographic factors associated with congenital heart \n        disease, such as age, race, ethnicity, sex, and family history \n        of individuals who are diagnosed with the disease; and\n            ``(E) evidence-based practices related to care and \n        treatment for individuals with congenital heart disease.\n        ``(2) Permissible considerations.--In carrying out the \n    activities under this section, the Secretary may, as appropriate--\n            ``(A) collect data on the health outcomes, including \n        behavioral and mental health outcomes, of a diverse population \n        of individuals of all ages with congenital heart disease, such \n        that analysis of the outcomes will inform evidence-based \n        practices for individuals with congenital heart disease; and\n            ``(B) consider health disparities among individuals with \n        congenital heart disease, which may include the consideration \n        of prenatal exposures.\n    ``(c) Awareness Campaign.--The Secretary may carry out awareness \nand educational activities related to congenital heart disease in \nindividuals of all ages, which may include information for patients, \nfamily members, and health care providers, on topics such as the \nprevalence of such disease, the effect of such disease on individuals \nof all ages, and the importance of long-term, specialized care for \nindividuals with such disease.\n    ``(d) Public Access.--The Secretary shall ensure that, subject to \nsubsection (e), information collected under this section is made \navailable, as appropriate, to the public, including researchers.\n    ``(e) Patient Privacy.--The Secretary shall ensure that the data \nand information collected under this section are made available in a \nmanner that, at a minimum, protects personal privacy to the extent \nrequired by applicable Federal and State law.\n    ``(f) Eligibility for Grants.--To be eligible to receive a grant \nunder subsection (a)(3), an entity shall--\n        ``(1) be a public or private nonprofit entity with specialized \n    experience in congenital heart disease; and\n        ``(2) submit to the Secretary an application at such time, in \n    such manner, and containing such information as the Secretary may \n    require.\n    ``(g) Authorization of Appropriations.--To carry out this section, \nthere are authorized to be appropriated $10,000,000 for each of fiscal \nyears 2020 through 2024.''.\nSEC. 3. REPORT.\n    Not later than 3 years after the date of enactment of the \nCongenital Heart Futures Reauthorization Act of 2017, the Secretary of \nHealth and Human Services shall submit to the Committee on Health, \nEducation, Labor, and Pensions of the Senate and the Committee on \nEnergy and Commerce of the House of Representatives a report \nsummarizing any activities carried out pursuant to section 399V-2 of \nthe Public Health Service Act (as amended by section 2), including \nplanned activities, and a summary of any research findings and ongoing \nresearch efforts, gaps, and areas of greatest need within the \nDepartment of Health and Human Services regarding congenital heart \ndisease in patients of all ages.\n\n                               Speaker of the House of Representatives.\n\n                            Vice President of the United States and    \n                                               President of the Senate."
}